TJ0113 capsules

DRUG2 trials

Sponsors

Yilai Shu, Hangzhou PhecdaMed Co., Ltd.

Conditions

Age Related Hearing LossDeafnessHealthy Subjects

Phase 1

Single Ascending Dose Study(SAD),Multiple Ascending Dose Study(MAD) , High-fat Diet Study (FE) of TJ0113 Capsules in Healthy Subjects

CompletedNCT07394452

Hangzhou PhecdaMed Co., Ltd.Healthy Subjects

Start: 2023-08-04End: 2024-04-03Updated: 2026-02-06

Unknown Phase

A Clinical Trial of the Safety and Efficacy of TJ0113 Capsules in the Treatment of Patients With Age-related Hearing Loss

Not yet recruitingNCT07012746

Yilai ShuAge Related Hearing Loss, Deafness

Start: 2025-06-07End: 2027-04-30Target: 60Updated: 2025-06-10